StockLearn from Clustermicro · Stock Breakout ScannerStockLearn

Evonile Pharma (EVONILE)

Other · NSE · end-of-day 2026-11-12

₹1,589.60

Day change

+1.37%

1-year

+125.7%

From 52-week high

-34.5%

Weinstein stage

Stage 2

Minervini template

6/8

Evonile Pharma closed at ₹1,589.60 on 2026-11-12, up 126% over the past year, 35% below its 52-week high. It meets 6 of 8 conditions of Minervini's trend template; Weinstein's stage analysis reads stage 2 - advancing. Over the year its annualised volatility was about 70%, with a largest fall of 35% from a peak.

Price, RSI and MACD

6M1Y2Y3Y

Price · +28.0% over the period

RSI (14) · 37.8

MACD (12, 26, 9) · histogram -16.93

Price · +121.7% over the period

RSI (14) · 37.8

MACD (12, 26, 9) · histogram -16.93

Price · +171.9% over the period

RSI (14) · 37.8

MACD (12, 26, 9) · histogram -16.93

Price · +139.9% over the period

RSI (14) · 37.8

MACD (12, 26, 9) · histogram -16.93

Price: daily close adjusted for splits and bonuses, dashed line the 150-day moving average. MACD: green line, orange dashed signal, bars the histogram. Longer periods are drawn from every second or third session.

Fundamentals

Market cap	Sales (TTM)	Net profit (TTM)	P/E	EPS (TTM)	P/B	ROE	Beta
—	—	—	—	—	—	—	—

Investor methods

Method	Checks	Score	Verdict
Minervini	✓ Close above the 150- and 200-day averages ✓ 150-day above 200-day ✓ 200-day rising for a month ✓ 50-day above the 150- and 200-day ✗ Close above the 50-day ✓ At least 25% above the 52-week low · low 672.25 ✗ Within 25% of the 52-week high · high 2,428.20 ✓ RS percentile 70 or more · RS 95 Minervini's trend template - the gate the scanner applies.	6/8	6 of 8
Weinstein	Stan Weinstein's stage analysis on the 30-week moving average.		Stage 2 - advancing
CAN SLIM	— C latest quarter EPS up 25%+, with sales up 25%+ or accelerating — A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✗ N (proxy) near the 52-week high - within 15% · high 2,428.20 ✓ S (proxy) more volume on up days than down days (50 sessions) · 2.85x ✓ L RS percentile 80 or more · RS 95 — I (proxy) FII + DII holding trend · not yet collected for this stock ✓ M (proxy) market in an uptrend, 40%+ of stocks above their 200-day - shared, not counted · breadth 55% William O'Neil's growth-leader checklist, as a checklist score: the six stock letters counted equally, though O'Neil read them together. M is the market condition, shown but not counted. N, S, I and M are proxies.	2/3	Average
Darvas	✓ Box top confirmed (3 sessions below the new high) · top 2,588.80 ✗ Box bottom confirmed (3 sessions holding) · bottom 1,530.40 ✓ Box at least 15 sessions old (~3 weeks) · 40 sessions ✗ Box no deeper than 25% · 41% deep ✗ Close above the box top · close 1,589.60 ✗ Volume at least 1.5x the previous 50 sessions' average · 0.3x Nicolas Darvas's box: a breakout above a confirmed box after a new high.	30/100	Forming
Turtle	✗ Close above the prior 55-session high · 2,588.80 ✗ Close above the prior 20-session high · 2,035.00 ✗ Close below the prior 20-session low (also a Turtle exit level) · 1,530.40 Turtle-inspired long breakout: the Turtle traders' entry channels only - no exits, stops or position sizing.		No signal
Graham	Needs positive earnings and book value.		Not assessable

Each method's own rules, applied to this stock - shown as information, not a buy or sell signal. All were tested on available data.

Other sector — top 10 by 1-year return

Stock	1M %	3M %	6M %	1Y %	3Y %	5Y %	P/E	P/B	ROE %	ROCE %	ROA %	D/E	EV/EBITDA	₹ Cr	Sales TTM ₹ Cr	Profit TTM ₹ Cr	EPS	Beta
EVONILE this stock	-21.0	-0.1	+25.9	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
SCPL	+8.7	+2.4	+56.9	+183.7	+92.7	—	31.3	4.20	13.2	—	—	0.57	16.1	701	395	22	21.3	0.47
PREMIERPOL	-22.6	+21.5	+62.2	+123.2	+172.4	+502.9	25.3	5.62	24.1	32.9	17.42	0.00	19.8	942	396	37	3.5	0.56
CALSOFT	-27.0	+35.9	+136.9	+63.2	+107.3	-14.3	12.2	4.33	32.3	42.0	27.61	0.04	—	—	25	15	2.4	0.62
DIGJAMLMTD	+34.2	+37.0	+47.3	+55.2	-19.8	+42.4	68.4	20.28	-20.3	5.2	-1.28	9.10	42.6	134	33	2	1.0	0.93
VALIANTLAB	+0.6	+107.2	+61.7	+52.1	-37.7	—	42.7	2.20	-1.2	0.8	-0.76	0.14	84.8	683	306	16	3.0	0.80
CHEMBONDCH	+6.0	-0.3	+26.4	+48.5	—	—	18.0	2.83	17.6	—	—	0.01	10.9	612	370	34	12.7	1.32
NILKAMAL	+22.4	+17.6	+65.9	+45.6	-1.4	-8.4	20.5	1.99	7.5	10.0	4.59	0.16	10.7	3,264	3,873	159	106.5	0.72
AKSHARCHEM	-2.9	+51.0	+89.2	+38.3	+45.2	-25.4	10.5	1.04	-0.2	0.7	-0.10	0.36	8.0	303	488	29	35.8	0.81
21STCENMGM	+67.7	+55.6	+74.2	+36.0	+253.1	+10.7	—	1.14	33.3	36.8	28.65	0.00	3.2	67	—	—	—	0.31
MARALOVER	+3.6	+7.2	+31.5	+29.6	-15.9	-23.3	—	2.21	—	—	—	—	—	—	—	—	—	1.02

Returns are total over each period, not annualised - 5Y is the whole five-year change. A blank in a return column means the stock is younger than that window. P/B and ROE come from each company's own filings where held.

Other stocks of a similar size

Meghna Infracon Infrastructure Lakshmi Mills Company K M C Speciality Hospitals (India)TGV Sraac Permanent Magnets Alufluoride Premco Global Fredun Pharmaceuticals

← All NSE stocks · More Other stocks

The live scanner - every stock ranked, filtered by method, stage and sector, with interactive charts - is in the StockLearn app. Open the StockLearn scanner →

Prices as of 2026-11-12, end of day, from NSE. Fundamentals from each company's own exchange filings (XBRL), EPS restated for splits and bonuses. Figures may be delayed and are for information only.

For research & education only — not investment advice. The methods, checks and verdicts are automated rules applied to public data, not buy/sell recommendations. StockLearn is an independent product of ClusterMicro Technologies, not affiliated with or endorsed by the NSE or any exchange. ClusterMicro Technologies is not a SEBI-registered investment adviser. Consult a SEBI-registered adviser before investing.

Terms · Privacy · Disclaimer · Refund · Contact